JAK2 V617F mutation in leukaemic transformation of philadelphia-negative chronic myeloproliferative disorders

Br J Haematol. 2006 Oct;135(2):267-8. doi: 10.1111/j.1365-2141.2006.06288.x. Epub 2006 Sep 4.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adult
  • Aged
  • Cell Transformation, Neoplastic / genetics
  • Female
  • Humans
  • Janus Kinase 2
  • Leukemia, Myeloid / genetics*
  • Male
  • Middle Aged
  • Myeloproliferative Disorders / genetics*
  • Philadelphia Chromosome
  • Protein-Tyrosine Kinases / genetics*
  • Proto-Oncogene Proteins / genetics*

Substances

  • Proto-Oncogene Proteins
  • Protein-Tyrosine Kinases
  • JAK2 protein, human
  • Janus Kinase 2